T

Theraly Fibrosis (acquired by D&D Pharmatech)

2 employees

Theraly is a preclinical-stage company whose mission is to develop innovative treatments for various forms of fibrotic disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical
Biopharma

Date founded

2015

Funding rounds raised

Total raised

$3.9M

from 1 investors over 1 rounds

T

Theraly Fibrosis (acquired by D&D Pharmatech) raised $3.9M on January 30, 2020

Investors: National Institutes of Health

FAQ